Evidence map›Paper›PMID 29912978›Full record

Trial reportPloS one2018

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial.

Iñigo Galilea-Zabalza, Pilar Buil-Cosiales, Jordi Salas-Salvadó, Estefanía Toledo, Carolina Ortega-Azorín, Javier Díez-Espino, Zenaida Vázquez-Ruiz, María Dolores Zomeño, Jesús Vioque, José Alfredo Martínez and 28 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 7 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 7 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Mediterranean Diet and its Benefits on Health and Mental Health: A Literature Review.Clinical practice and epidemiology in mental health : CP & EMH · 2020
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Integrative development of a short screening questionnaire of highly processed food consumption (sQ-HPF).The international journal of behavioral nutrition and physical activity · 2022
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Observational

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 16 institutions in 3 countries.

Iñigo Galilea-ZabalzaAtención Primaria. Osasunbidea-Servicio Navarro de Salud. Pamplona, Spain.
Pilar Buil-CosialesAtención Primaria. Osasunbidea-Servicio Navarro de Salud. Pamplona, Spain.
Jordi Salas-SalvadóCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Estefanía ToledoCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Carolina Ortega-AzorínCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Javier Díez-EspinoAtención Primaria. Osasunbidea-Servicio Navarro de Salud. Pamplona, Spain.
Zenaida Vázquez-RuizCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
María Dolores ZomeñoCardiovascular Risk and Nutrition, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
Jesús VioqueCIBER Epidemiología y Salud Pública (CIBEResp), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
José Alfredo MartínezCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Dora RomagueraCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Napoleón Perez-FarinosSchool of Nursing, University of Málaga, Málaga, Spain.
José López-MirandaCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Ramón EstruchCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Aurora Bueno-CavanillasBlanquerna School of Life Sciences, Universitat Ramon Llull, Barcelona, Spain.
Fernando ArósCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Josep Antoni TurCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Francisco TinahonesCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lluis Serra-MajemCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Alba Marcos-DelgadoBlanquerna School of Life Sciences, Universitat Ramon Llull, Barcelona, Spain.
Manuel Ortega-CalvoCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0003-2391-0106
Clotilde VázquezCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Xavier PintóCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Josep VidalCIBER Diabetes y enfermedades metabólicas (CIBERdem), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lidia DaimielNutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
Miguel Delgado-RodríguezBlanquerna School of Life Sciences, Universitat Ramon Llull, Barcelona, Spain.
Pilar MatíaInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.
Dolores CorellaCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Andrés Diaz-LópezCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-7500-5629
Nancy BabioHuman Nutrition Unit, IISPV, Universitat Rovira i Virgili, Reus, Spain.
Miguel Angel MuñozCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Montse FitóCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Sandra González-PalaciosCIBER Epidemiología y Salud Pública (CIBEResp), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Itziar AbeteDepartment of Nutrition and Food Sciences, Physiology and Toxicology, University of Navarra, Pamplona, Spain.
Antonio García-RiosDepartment of Internal Medicine, Reina Sofia University Hospital, University of Córdoba-IMIBIC, Córdoba, Spain.
Emilio RosCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Miguel Ángel Martínez-GonzálezCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-3917-9808
PREDIMED-PLUS Study Investigators
Instituto de Salud Carlos III · ESUniversitat de Miguel Hernández d'Elx · ESUniversitat de València · ESHarvard University · USHospital Del Mar · ESInstitut de Recerca Biomèdica Catalunya Sud · ESInstitute for Biomedicine · ITInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESMadrid Institute for Advanced Studies · ESUniversidad de Granada · ESUniversidad de Jaén · ESUniversidad de Las Palmas de Gran Canaria · ESUniversidad de Málaga · ESUniversidad de Navarra · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire that assessed adherence to an MedDiet. We used ANCOVA and multivariable-adjusted linear regression models to compare baseline adjusted means of the quality of life scales according to categories of adherence to the MedDiet. Higher adherence to the MedDiet was independently associated with significantly better scores in the eight dimensions of HRQoL. Adjusted differences of > = 3 points between the highest and the lowest dietary adherence groups to the MedDiet were observed for vitality, emotional role, and mental health and of > = 2 points for the other dimensions. In conclusion, this study shows a positive association between adherence to a MedDiet and several dimensions of quality of life.

Indexed as

Diet, MediterraneanQuality of LifeAgedCross-Sectional StudiesExercise TherapyFemaleHumansMaleMetabolic SyndromeMiddle AgedObesityOverweightPatient ComplianceSpain

Identifiers

PMID29912978
PMCPMC6005498
OpenAlexW2809086593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.